AKT1 and osteosarcoma: In osteosarcoma treatment, ginsenoside Rg3 inhibited the proliferation and migration of osteosarcoma cells and induced apoptosis by reducing the protein expression of Bcl 2 and the PI3K/AKT pathway [206].